New Current Report Filed with the SEC Disclosing Occurrence of a Triggering Event That Accelerates or Increases a Financial Obligation: 8-K – Evoke Pharma Inc (0001403708) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing the occurrence of an event that triggers the acceleration of or increase in a direct financial obligation or an obligation under an off-balance sheet arrangement. Details of the current report are:

8-K – Evoke Pharma Inc (0001403708) (Filer)
Filed: 2016-07-20 AccNo: 0001193125-16-651782 Size: 423 KB

Item 1.01: Entry into a Material Definitive Agreement

Item 2.02: Results of Operations and Financial Condition

Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Item 3.02: Unregistered Sales of Equity Securities

Item 7.01: Regulation FD Disclosure

Item 8.01: Other Events

Item 9.01: Financial Statements and Exhibits
Filing Date: 2016-07-20T07:54:33-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: